Furner R L, Mellett L B, Herren T C
J Pharmacol Exp Ther. 1975 Jul;194(1):103-10.
The phosphorylation of 1-beta-D-arabinofuranosylcytosine (ara-C) was studied in cell-free extracts from a variety of solid mouse tumors, L1210 ascites and in normal liver and spleen. Two apparent Michaelis constants were observed for kinase activity in Lewis lung (Km1, 4.15 muM; Km2 58.1 muM), sarcoma 180 (Km1 6.66 muM; Km2 56.18 muM), adenocarcinoma 755 (Km1 4.34 muM; Km2 50.0 muM) and l1210 (Km1 29.41 muM; Km2 41.67 muM). The Km1 values generally ranged from 5 to 20 muM 3H-ara-C while the Km2 values ranged from 20 to 60 muM 3H-ara-C. Normal spleen (Km 47.6 muM), normal liver (Km 10.0 muM) and Ridgway osteogenic sarcoma (Km 31.2 muM) had single Km values. In the presence of tetrahydrouridine (H4U), the in vitro phosphorylation of ara-C was increased as much as 91% in cell-free extracts from adenocarcinoma 755; lesser increases were observed in other tumor extracts. At low substrate concentrations, the apparent Km decreased or did not change in the presence of H4U, while at higher substrate concentrations the apparent Km was increased or did not change in the presence of H4U. In the presence of H4U, Vmax for kinase activity increased most in those tumors possessing deaminase activity.
对1-β-D-阿拉伯呋喃糖基胞嘧啶(阿糖胞苷,ara-C)的磷酸化作用在多种小鼠实体瘤、L1210腹水瘤以及正常肝脏和脾脏的无细胞提取物中进行了研究。在Lewis肺癌(Km1,4.15 μM;Km2 58.1 μM)、肉瘤180(Km1 6.66 μM;Km2 56.18 μM)、腺癌755(Km1 4.34 μM;Km2 50.0 μM)和L1210(Km1 29.41 μM;Km2 41.67 μM)中观察到激酶活性有两个明显的米氏常数。Km1值一般在5至20 μM 3H-阿糖胞苷范围内,而Km2值在20至60 μM 3H-阿糖胞苷范围内。正常脾脏(Km 47.6 μM)、正常肝脏(Km 10.0 μM)和Ridgway成骨肉瘤(Km 31.2 μM)有单一的Km值。在四氢尿苷(H4U)存在的情况下,腺癌755无细胞提取物中阿糖胞苷的体外磷酸化作用增加了多达91%;在其他肿瘤提取物中观察到的增加幅度较小。在低底物浓度下,在H4U存在时表观Km降低或不变,而在高底物浓度下,在H4U存在时表观Km增加或不变。在H4U存在的情况下,激酶活性的Vmax在具有脱氨酶活性的那些肿瘤中增加最多。